DrugPatentWatch Database Preview

Lanreotide acetate - Generic Drug Details

What are the generic sources for lanreotide acetate and what is the scope of lanreotide acetate freedom to operate?

Lanreotide acetate is the generic ingredient in one branded drug marketed by Ipsen Pharma and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for lanreotide acetate. One supplier is listed for this compound.

Summary for lanreotide acetate

US Patents:	1
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	3
Suppliers / Packagers:	1
Bulk Api Vendors:	24
Clinical Trials:	3
Patent Applications:	4,927
DailyMed Link:	lanreotide acetate at DailyMed

Pharmacology for lanreotide acetate

Drug Class	Somatostatin Analog
Mechanism of Action	Somatostatin Receptor Agonists

Synonyms for lanreotide acetate

10-(4-Aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacy
10-(4-aminobutyl)-19-[[2-amino-3-(2-naphthyl)propanoyl]amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan
10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazac
108736-35-2
127984-74-1
3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-->7)-disulfide acetate
33928-EP2272827A1
33928-EP2275420A1
33928-EP2295055A2
33928-EP2295416A2
33928-EP2295426A1
33928-EP2295427A1
33928-EP2298748A2
33928-EP2298764A1
33928-EP2298765A1
33928-EP2305642A2
33928-EP2311453A1
33928-EP2311808A1
33928-EP2311829A1
AC1L2FZT
AN-33681
Angiopeptin
Angiopeptin acetate
Autogel
BIM 23014
Bim-23014
C54H69N11O10S2
CHEBI:135901
CTK8G7572
D0M2YE
D0V1SB
DB06791
DC 13-116
GTPL2031
L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
L000343
Lanreotida [INN-Spanish]
Lanreotide
Lanreotide [INN:BAN]
Lanreotide Autogel
Lanreotidum [INN-Latin]
LS-153748
LS-172394
Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2
NCGC00181321-01
PUDHBTGHUJUUFI-UHFFFAOYSA-N
SCHEMBL14802383
SCHEMBL34091
Somatulin
Somatulin-Autogel
Somatuline
Somatuline lp (TN)

US Patents and Regulatory Information for lanreotide acetate

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-002	Aug 30, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-001	Aug 30, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-002	Aug 30, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-002	Aug 30, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for lanreotide acetate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
China	1165479	➤ Sign Up
China	1846669	➤ Sign Up
Austria	306906	➤ Sign Up
European Patent Office	1270032	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for lanreotide acetate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
037	Luxembourg	➤ Sign Up	91037, EXPIRES: 20160511
2002 00032	Denmark	➤ Sign Up
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description